Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

NCT03741192 is registered in ClinicalTrials.gov with Brain Sentinel as lead sponsor.

NCT NCT03741192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03741192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs
Lead sponsor
Brain Sentinel
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2020
Completion date
January 31, 2026
Enrollment
58 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy intractable